Healthcare provider profile · identity verified

John M Lopez, M.D.

Internal Medicine · KENOSHA, WI · NPI 1487677316

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	729	200
Amlodipine Besylate	Amlodipine Besylate	512	141
Levothyroxine Sodium	Levothyroxine Sodium	417	114
Omeprazole	Omeprazole	296	84
Pravastatin Sodium	Pravastatin Sodium	235	66
Losartan Potassium	Losartan Potassium	232	58
Valsartan	Valsartan	211	53
Metoprolol Succinate	Metoprolol Succinate	210	63
Hydrochlorothiazide	Hydrochlorothiazide	188	54
Alendronate Sodium	Alendronate Sodium	184	46
Lisinopril	Lisinopril	182	58
Pantoprazole Sodium	Pantoprazole Sodium	171	53
Metformin Hcl	Metformin Hcl	156	44
Rosuvastatin Calcium	Rosuvastatin Calcium	148	44
Prednisone	Prednisone	145	126
Gabapentin	Gabapentin	138	34
Sertraline Hcl	Sertraline Hcl	132	37
Glipizide	Glipizide	131	36
Potassium Chloride	Potassium Chloride	125	35
Trazodone Hcl	Trazodone Hcl	123	33
Metformin Hcl Er	Metformin Hcl	122	33
Furosemide	Furosemide	116	46
Mounjaro	Tirzepatide	111	27
Tamsulosin Hcl	Tamsulosin Hcl	107	31
Carvedilol	Carvedilol	103	36
Allopurinol	Allopurinol	101	29
Metoprolol Tartrate	Metoprolol Tartrate	97	27
Simvastatin	Simvastatin	93	23
Enalapril Maleate	Enalapril Maleate	90	23
Clopidogrel	Clopidogrel Bisulfate	84	26
Amoxicillin	Amoxicillin	83	77
Mirtazapine	Mirtazapine	75	17
Albuterol Sulfate Hfa	Albuterol Sulfate	74	33
Nortriptyline Hcl	Nortriptyline Hcl	73	16
Labetalol Hcl	Labetalol Hcl	72	20
Montelukast Sodium	Montelukast Sodium	65	15
Ozempic	Semaglutide	64	15
Venlafaxine Hcl Er	Venlafaxine Hcl	59	19
Jardiance	Empagliflozin	55	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	15
Warfarin Sodium	Warfarin Sodium	52	suppressed
Finasteride	Finasteride	49	15
Rybelsus	Semaglutide	49	suppressed
Ezetimibe	Ezetimibe	48	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	13
Xarelto	Rivaroxaban	42	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	15
Buspirone Hcl	Buspirone Hcl	37	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Glimepiride	Glimepiride	35	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	35	14
Terazosin Hcl	Terazosin Hcl	34	suppressed
Meloxicam	Meloxicam	33	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	23
Paroxetine Hcl	Paroxetine Hcl	31	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Azithromycin	Azithromycin	26	26
Chlorthalidone	Chlorthalidone	25	suppressed
Famotidine	Famotidine	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Minoxidil	Minoxidil	25	suppressed
Levofloxacin	Levofloxacin	24	23
Risperidone	Risperidone	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Pregabalin	Pregabalin	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Ramipril	Ramipril	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Eliquis	Apixaban	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Atenolol	Atenolol	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Lorazepam	Lorazepam	17	suppressed
Lubiprostone	Lubiprostone	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Topiramate	Topiramate	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Trulicity	Dulaglutide	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Tramadol Hcl Er	Tramadol Hcl	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	12
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error